HopeStage
Back to all studies
RecruitingNCT06385223

Personalized or standard-targeted theta-burst stimulation for depression

About this titleRead the official source — NCT06385223
Device studyAges 21+Singapore
The study in practice

Understand this study

Who could participate?

Listed age limits: from 21 years.

Listed locations
SingaporeSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: July 1, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
70
Sponsor
Institute of Mental Health, Singapore
Sponsor type
Research institute
Study type
Device
Intervention type
Device
Locations
Singapore
Age range
Over 21 Years
Official registry ID
NCT06385223
Official title
Show the full official title

A Novel Individualized Connectome-guided Approach for Precision Intermittent Theta Burst Stimulation for Depression: a Double Blind, Randomized Controlled Trial

Recruitment & locations

Currently recruiting

Singapore

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Institute of Mental Health, Singapore, a research institute.

Who can participate?

Listed age limits: from 21 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies